Sign in

CIK 0001061983 · Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
943291317
Phone
(650) 624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale EVP Research & Development sold 3,500 shares at $80.59 ($282,065)
  2. 4 Grant or award Director acquired 75 shares (grant or award)
  3. 4 Grant or award Director acquired 75 shares (grant or award)
  4. 4 Grant or award Director acquired 151 shares (grant or award)
  5. 4 Grant or award Director acquired 272 shares (grant or award)
  6. 4 Grant or award Director acquired 151 shares (grant or award)
  7. 4 Grant or award Director acquired 151 shares (grant or award)
  8. 4 Planned sale President & CEO sold 7,500 shares at $82.02 ($615,150)
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. 4 Planned sale EVP Research & Development sold 3,500 shares at $86.62 ($303,170)
  11. 144 Insider Sale of Securities
  12. 4 Planned sale President & CEO sold 7,500 shares at $84.92 ($636,900)
  13. 4 Planned sale EVP, Chief Commercial Officer sold 15,000 shares at $85.80 ($1,287,000)
  14. 4 Planned sale EVP, Chief Financial Officer sold 1,112 shares at $87.79 ($97,622)
  15. 144 Insider Sale of Securities
  16. 4 Planned sale EVP, Chief Financial Officer sold 38,730 shares at $82.30 ($3,187,479)
  17. 4 Planned sale EVP, Chief Financial Officer sold 3,134 shares at $85.00 ($266,390)
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 3 of 127 · 2,534 filings